Review



plex307 ace2 blast  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc plex307 ace2 blast
    Plex307 Ace2 Blast, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plex307 ace2 blast/product/Addgene inc
    Average 93 stars, based on 8 article reviews
    plex307 ace2 blast - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    93
    Addgene inc plex307 ace2 blast
    Plex307 Ace2 Blast, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plex307 ace2 blast/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    plex307 ace2 blast - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Addgene inc plex307 ace2blast
    Plex307 Ace2blast, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plex307 ace2blast/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    plex307 ace2blast - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Addgene inc hnepc cells
    (A) Representative brightfield images of <t>A549ACE2</t> <t>TP53ko</t> pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Scale bars, 200 μm. (B) Top, western blotting analysis of whole cell lysates of A549ACE2 or A549ACE2 TP53ko pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Relative ratios of TP53/ACTB (normalized to EGFP -Dox) are annotated below TP53. Bottom, western blotting analysis of supernatants (SUP) of the corresponding cell constructs and treatments. (C) MSigDB pathway enrichment analysis of differential RNA-seq profiles upon doxycycline-induced expression (48 h, 1 μg/mL) of SARS-CoV-2 ancestral or Delta spike relative to expression of EGFP in either A549ACE2 or A549ACE2 TP53ko pInducer20 cells. n = 2 technical replicates/group. (D) Cell viability as assessed by CellTiter-Glo in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 72 h (mean ± SEM). The Welch two-sample t test with Holm p value correction was used to assess statistical significance: ***p < 0.001; **p < 0.01. n = 5 technical replicates/group. (E) RNA levels of CDKN1A by RT-qPCR in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 48 h (mean ± SEM). The Welch two-sample t test with Benjamini-Hochberg p value correction was used to assess statistical significance relative to the EGFP -Dox condition: ***p < 0.001; **p < 0.01; *p < 0.05; n.s., not significant. n = 4 technical replicates/group. (F) Senescence-associated beta-galactosidase activity in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 48 h (mean ± SEM). The Welch two-sample t test with Holm p value correction was used to assess statistical significance: **p < 0.01; n.s., not significant. n = 14 technical replicates/group. (G) Left, ATAC-seq volcano plots of ancestral or Delta spike vs. EGFP expression in A549ACE2 pInducer20 cells 48 h after 1 μg/mL doxycycline induction. Right, number of significant (FDR < 0.05) ATAC-seq peaks upon doxycycline-induced expression (48 h, 1 μg/mL) of SARS-CoV-2 ancestral or Delta spike relative to expression of EGFP in either A549ACE2 or A549ACE2 TP53ko pInducer20 cells. Black triangles, peaks with increasing accessibility. Red circles, peaks with decreasing accessibility. n = 2 technical replicates/group. (H) Left, heatmap of relative levels of differentially expressed microRNAs (FDR < 0.05 and base mean > 10) from ancestral or Delta spike vs. EGFP expression in A549ACE2 or A549ACE2 TP53ko pInducer20 cells 48 h after 1 μg/mL doxycycline induction. Right, number of significant (FDR < 0.05) differentially expressed microRNAs upon doxycycline-induced expression (48 h, 1 μg/mL) of ancestral or Delta spike vs. EGFP expression in A549ACE2 or A549ACE2 TP53ko pInducer20 cells. Black triangles, significantly upregulated microRNAs. Red circles, significantly downregulated microRNAs. n = 2 technical replicates/group. (I) Heatmap of relative levels of cytokines in supernatants of A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with 1 μg/mL doxycycline for 48 h. The Welch two-sample t test with Benjamini-Hochberg p value correction was used to assess statistical significance. Sig, FDR < 0.05. n = 4 technical replicates/group. (J) Representative brightfield images of <t>HNEpC</t> (human nasal epithelial cell)-ACE2 pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Scale bars, 200 μm. (K) Western blotting analysis of supernatants of HNEpC-ACE2 pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h.
    Hnepc Cells, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hnepc cells/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    hnepc cells - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Representative brightfield images of A549ACE2 TP53ko pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Scale bars, 200 μm. (B) Top, western blotting analysis of whole cell lysates of A549ACE2 or A549ACE2 TP53ko pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Relative ratios of TP53/ACTB (normalized to EGFP -Dox) are annotated below TP53. Bottom, western blotting analysis of supernatants (SUP) of the corresponding cell constructs and treatments. (C) MSigDB pathway enrichment analysis of differential RNA-seq profiles upon doxycycline-induced expression (48 h, 1 μg/mL) of SARS-CoV-2 ancestral or Delta spike relative to expression of EGFP in either A549ACE2 or A549ACE2 TP53ko pInducer20 cells. n = 2 technical replicates/group. (D) Cell viability as assessed by CellTiter-Glo in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 72 h (mean ± SEM). The Welch two-sample t test with Holm p value correction was used to assess statistical significance: ***p < 0.001; **p < 0.01. n = 5 technical replicates/group. (E) RNA levels of CDKN1A by RT-qPCR in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 48 h (mean ± SEM). The Welch two-sample t test with Benjamini-Hochberg p value correction was used to assess statistical significance relative to the EGFP -Dox condition: ***p < 0.001; **p < 0.01; *p < 0.05; n.s., not significant. n = 4 technical replicates/group. (F) Senescence-associated beta-galactosidase activity in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 48 h (mean ± SEM). The Welch two-sample t test with Holm p value correction was used to assess statistical significance: **p < 0.01; n.s., not significant. n = 14 technical replicates/group. (G) Left, ATAC-seq volcano plots of ancestral or Delta spike vs. EGFP expression in A549ACE2 pInducer20 cells 48 h after 1 μg/mL doxycycline induction. Right, number of significant (FDR < 0.05) ATAC-seq peaks upon doxycycline-induced expression (48 h, 1 μg/mL) of SARS-CoV-2 ancestral or Delta spike relative to expression of EGFP in either A549ACE2 or A549ACE2 TP53ko pInducer20 cells. Black triangles, peaks with increasing accessibility. Red circles, peaks with decreasing accessibility. n = 2 technical replicates/group. (H) Left, heatmap of relative levels of differentially expressed microRNAs (FDR < 0.05 and base mean > 10) from ancestral or Delta spike vs. EGFP expression in A549ACE2 or A549ACE2 TP53ko pInducer20 cells 48 h after 1 μg/mL doxycycline induction. Right, number of significant (FDR < 0.05) differentially expressed microRNAs upon doxycycline-induced expression (48 h, 1 μg/mL) of ancestral or Delta spike vs. EGFP expression in A549ACE2 or A549ACE2 TP53ko pInducer20 cells. Black triangles, significantly upregulated microRNAs. Red circles, significantly downregulated microRNAs. n = 2 technical replicates/group. (I) Heatmap of relative levels of cytokines in supernatants of A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with 1 μg/mL doxycycline for 48 h. The Welch two-sample t test with Benjamini-Hochberg p value correction was used to assess statistical significance. Sig, FDR < 0.05. n = 4 technical replicates/group. (J) Representative brightfield images of HNEpC (human nasal epithelial cell)-ACE2 pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Scale bars, 200 μm. (K) Western blotting analysis of supernatants of HNEpC-ACE2 pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h.

    Journal: Cell reports

    Article Title: Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53

    doi: 10.1016/j.celrep.2023.113478

    Figure Lengend Snippet: (A) Representative brightfield images of A549ACE2 TP53ko pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Scale bars, 200 μm. (B) Top, western blotting analysis of whole cell lysates of A549ACE2 or A549ACE2 TP53ko pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Relative ratios of TP53/ACTB (normalized to EGFP -Dox) are annotated below TP53. Bottom, western blotting analysis of supernatants (SUP) of the corresponding cell constructs and treatments. (C) MSigDB pathway enrichment analysis of differential RNA-seq profiles upon doxycycline-induced expression (48 h, 1 μg/mL) of SARS-CoV-2 ancestral or Delta spike relative to expression of EGFP in either A549ACE2 or A549ACE2 TP53ko pInducer20 cells. n = 2 technical replicates/group. (D) Cell viability as assessed by CellTiter-Glo in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 72 h (mean ± SEM). The Welch two-sample t test with Holm p value correction was used to assess statistical significance: ***p < 0.001; **p < 0.01. n = 5 technical replicates/group. (E) RNA levels of CDKN1A by RT-qPCR in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 48 h (mean ± SEM). The Welch two-sample t test with Benjamini-Hochberg p value correction was used to assess statistical significance relative to the EGFP -Dox condition: ***p < 0.001; **p < 0.01; *p < 0.05; n.s., not significant. n = 4 technical replicates/group. (F) Senescence-associated beta-galactosidase activity in the indicated A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with or without 1 μg/mL doxycycline (Dox) for 48 h (mean ± SEM). The Welch two-sample t test with Holm p value correction was used to assess statistical significance: **p < 0.01; n.s., not significant. n = 14 technical replicates/group. (G) Left, ATAC-seq volcano plots of ancestral or Delta spike vs. EGFP expression in A549ACE2 pInducer20 cells 48 h after 1 μg/mL doxycycline induction. Right, number of significant (FDR < 0.05) ATAC-seq peaks upon doxycycline-induced expression (48 h, 1 μg/mL) of SARS-CoV-2 ancestral or Delta spike relative to expression of EGFP in either A549ACE2 or A549ACE2 TP53ko pInducer20 cells. Black triangles, peaks with increasing accessibility. Red circles, peaks with decreasing accessibility. n = 2 technical replicates/group. (H) Left, heatmap of relative levels of differentially expressed microRNAs (FDR < 0.05 and base mean > 10) from ancestral or Delta spike vs. EGFP expression in A549ACE2 or A549ACE2 TP53ko pInducer20 cells 48 h after 1 μg/mL doxycycline induction. Right, number of significant (FDR < 0.05) differentially expressed microRNAs upon doxycycline-induced expression (48 h, 1 μg/mL) of ancestral or Delta spike vs. EGFP expression in A549ACE2 or A549ACE2 TP53ko pInducer20 cells. Black triangles, significantly upregulated microRNAs. Red circles, significantly downregulated microRNAs. n = 2 technical replicates/group. (I) Heatmap of relative levels of cytokines in supernatants of A549ACE2 or A549ACE2 TP53ko pInducer20 cells treated with 1 μg/mL doxycycline for 48 h. The Welch two-sample t test with Benjamini-Hochberg p value correction was used to assess statistical significance. Sig, FDR < 0.05. n = 4 technical replicates/group. (J) Representative brightfield images of HNEpC (human nasal epithelial cell)-ACE2 pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h. Scale bars, 200 μm. (K) Western blotting analysis of supernatants of HNEpC-ACE2 pInducer20 cells transduced with the indicated gene constructs and treated with or without 1 μg/mL doxycycline (Dox) for 48 h.

    Article Snippet: A549, A549 TP53ko, and HNEpC cells were transduced with pLEX307-ACE2-blast (Addgene #158449) to generate A549ACE2, A549ACE2 TP53ko, and HNEpC-ACE2 cell lines.

    Techniques: Transduction, Construct, Western Blot, RNA Sequencing, Expressing, Quantitative RT-PCR, Activity Assay

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53

    doi: 10.1016/j.celrep.2023.113478

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: A549, A549 TP53ko, and HNEpC cells were transduced with pLEX307-ACE2-blast (Addgene #158449) to generate A549ACE2, A549ACE2 TP53ko, and HNEpC-ACE2 cell lines.

    Techniques: FLAG-tag, Luciferase, Virus, Recombinant, Reverse Transcription, SYBR Green Assay, Activity Assay, Software, CRISPR